{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:43:33Z","timestamp":1790891013928,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"crossref","award":["23JRRA0929"],"award-info":[{"award-number":["23JRRA0929"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"crossref","award":["23JRRA1601"],"award-info":[{"award-number":["23JRRA1601"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82360510"],"award-info":[{"award-number":["82360510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260555"],"award-info":[{"award-number":["82260555"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Lanzhou Science and Technology Plan Project","award":["2023-2-38"],"award-info":[{"award-number":["2023-2-38"]}]},{"name":"The Fund of The First Hospital of Lanzhou University","award":["ldyyyn2022-12"],"award-info":[{"award-number":["ldyyyn2022-12"]}]},{"name":"Chengguan District Science and Technology Plan","award":["2023SHFZ0018"],"award-info":[{"award-number":["2023SHFZ0018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13876-9","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T09:22:51Z","timestamp":1741944171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Establishment and characterization of CHC-X1: the third human combined hepatocellular\u2013cholangiocarcinoma cell line"],"prefix":"10.1186","volume":"25","author":[{"given":"Huan","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changpeng","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhui","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linpei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wence","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"issue":"5","key":"13876_CR1","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jhep.2021.01.035","volume":"74","author":"A Beaufr\u00e8re","year":"2021","unstructured":"Beaufr\u00e8re A, Calderaro J, Paradis V. Combined hepatocellular-cholangiocarcinoma: an update. J Hepatol. 2021;74(5):1212\u201324.","journal-title":"J Hepatol"},{"issue":"8","key":"13876_CR2","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/lt.23897","volume":"20","author":"M Garancini","year":"2014","unstructured":"Garancini M, Goffredo P, Pagni F, Romano F, Roman S, Sosa JA, et al. Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor. Liver Transpl. 2014;20(8):952\u20139.","journal-title":"Liver Transpl"},{"issue":"2","key":"13876_CR3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.15403\/jgld-4893","volume":"32","author":"A Teufel","year":"2023","unstructured":"Teufel A, Rodriguez I, Winzler C, Kokh D, Ebert MP, Surovtsova I, et al. Clinical characterization of HCC\/CCA mixed cancers in a Population-based cohort. J Gastrointestin Liver Dis. 2023;32(2):190\u20136.","journal-title":"J Gastrointestin Liver Dis"},{"key":"13876_CR4","doi-asserted-by":"publisher","first-page":"906778","DOI":"10.3389\/fonc.2022.906778","volume":"12","author":"J Lin","year":"2022","unstructured":"Lin J, Zhang H, Yu H, Bi X, Zhang W, Yin J, et al. Epidemiological characteristics of primary liver Cancer in Mainland China from 2003 to 2020: A representative multicenter study. Front Oncol. 2022;12:906778.","journal-title":"Front Oncol"},{"issue":"10","key":"13876_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/hepr.13953","volume":"53","author":"H Iijima","year":"2023","unstructured":"Iijima H, Kudo M, Kubo S, Kurosaki M, Sakamoto M, Shiina S, et al. Report of the 23rd nationwide follow-up survey of primary liver cancer in Japan (2014\u20132015). Hepatol Res. 2023;53(10):895\u2013959.","journal-title":"Hepatol Res"},{"issue":"9","key":"13876_CR6","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.14309\/ajg.0000000000000326","volume":"114","author":"D Ramai","year":"2019","unstructured":"Ramai D, Ofosu A, Lai JK, Reddy M, Adler DG. Combined hepatocellular cholangiocarcinoma: A Population-Based retrospective study. Am J Gastroenterol. 2019;114(9):1496\u2013501.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"13876_CR7","doi-asserted-by":"publisher","first-page":"100783","DOI":"10.1016\/j.esmoop.2023.100783","volume":"8","author":"K Pomej","year":"2023","unstructured":"Pomej K, Balcar L, Shmanko K, Welland S, Himmelsbach V, Scheiner B, et al. Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma-a European multicenter cohort. ESMO Open. 2023;8(1):100783.","journal-title":"ESMO Open"},{"issue":"1","key":"13876_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000503719","volume":"9","author":"D Gentile","year":"2020","unstructured":"Gentile D, Donadon M, Lleo A, Aghemo A, Roncalli M, di Tommaso L, et al. Surgical treatment of hepatocholangiocarcinoma: A systematic review. Liver Cancer. 2020;9(1):15\u201327.","journal-title":"Liver Cancer"},{"issue":"4","key":"13876_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/his.14384","volume":"79","author":"CC Yen","year":"2021","unstructured":"Yen CC, Yen CJ, Shan YS, Lin YJ, Liu IT, Huang HY, et al. Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated world health organization classification. Histopathology. 2021;79(4):556\u201372.","journal-title":"Histopathology"},{"issue":"6","key":"13876_CR10","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/jgh.14547","volume":"34","author":"K Wakizaka","year":"2019","unstructured":"Wakizaka K, Yokoo H, Kamiyama T, Ohira M, Kato K, Fujii Y, et al. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers. J Gastroenterol Hepatol. 2019;34(6):1074\u201380.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"13876_CR11","doi-asserted-by":"publisher","first-page":"100745","DOI":"10.1016\/j.jhepr.2023.100745","volume":"5","author":"MPAW Claasen","year":"2023","unstructured":"Claasen MPAW, Ivanics T, Beumer BR, de Wilde RF, Polak WG, Sapisochin G, et al. An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma. JHEP Rep. 2023;5(6):100745.","journal-title":"JHEP Rep"},{"key":"13876_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/JHC.S159805","volume":"6","author":"C Stavraka","year":"2018","unstructured":"Stavraka C, Rush H, Ross P. Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions. J Hepatocell Carcinoma. 2018;6:11\u201321.","journal-title":"J Hepatocell Carcinoma"},{"key":"13876_CR13","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/ncomms3126","volume":"4","author":"S Domcke","year":"2013","unstructured":"Domcke S, Sinha R, Levine DA, Sander C, Schultz N. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat Commun. 2013;4:2126.","journal-title":"Nat Commun"},{"issue":"7391","key":"13876_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The Cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483(7391):603\u20137.","journal-title":"Nature"},{"key":"13876_CR15","doi-asserted-by":"crossref","unstructured":"Murakami T, Yano H, Maruiwa M, Sugihara S, Kojiro M. Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude mice. Hepatol. 1987; May-Jun;7(3):551\u20136.","DOI":"10.1002\/hep.1840070322"},{"issue":"4","key":"13876_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0168-8278(96)80161-9","volume":"24","author":"H Yano","year":"1996","unstructured":"Yano H, Iemura A, Haramaki M, Momosaki S, Ogasawara S, Higaki K, et al. A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions. J Hepatol. 1996;24(4):413\u201322.","journal-title":"J Hepatol"},{"issue":"1","key":"13876_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s13577-022-00797-z","volume":"36","author":"H Xu","year":"2023","unstructured":"Xu H, Miao X, Chai C, Tang H, Hu J, Zhao Z, et al. Establishment and characterization of a new Chinese hepatocellular carcinoma cell line, Hep-X1. Hum Cell. 2023;36(1):434\u201345.","journal-title":"Hum Cell"},{"issue":"1","key":"13876_CR18","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s12935-022-02840-3","volume":"22","author":"X Miao","year":"2022","unstructured":"Miao X, Hu J, Chai C, Tang H, Zhao Z, Luo W, et al. Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line derived from a Chinese patient. Cancer Cell Int. 2022;22(1):418.","journal-title":"Cancer Cell Int"},{"key":"13876_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.humpath.2019.11.001","volume":"96","author":"A Sciarra","year":"2020","unstructured":"Sciarra A, Park YN, Sempoux C. Updates in the diagnosis of combined hepatocellular-cholangiocarcinoma. Hum Pathol. 2020;96:48\u201355.","journal-title":"Hum Pathol"},{"issue":"5","key":"13876_CR20","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00428-017-2196-x","volume":"471","author":"C De Vito","year":"2017","unstructured":"De Vito C, Sarker D, Ross P, Heaton N, Quaglia A. Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series. Virchows Arch. 2017;471(5):619\u201329.","journal-title":"Virchows Arch"},{"issue":"2","key":"13876_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/JTO.0000000000000033","volume":"9","author":"Y Shi","year":"2014","unstructured":"Shi Y, Au JS, Thongprasert S, Srinivasan S, Tsai CM, Khoa MT, et al. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER). J Thorac Oncol. 2014;9(2):154\u201362.","journal-title":"J Thorac Oncol"},{"issue":"9","key":"13876_CR22","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1245\/s10434-015-4388-4","volume":"22","author":"J Wang","year":"2015","unstructured":"Wang J, Sun Y, Bertagnolli MM. Comparison of gastric cancer survival between Caucasian and Asian patients treated in the united States: results from the surveillance epidemiology and end results (SEER) database. Ann Surg Oncol. 2015;22(9):2965\u201371.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"13876_CR23","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1136\/gutjnl-2014-308252","volume":"64","author":"SJ Lin","year":"2015","unstructured":"Lin SJ, Gagnon-Bartsch JA, Tan IB, Earle S, Ruff L, Pettinger K, et al. Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas. Gut. 2015;64(11):1721\u201331.","journal-title":"Gut"},{"key":"13876_CR24","first-page":"260","volume-title":"WHO classification of tumours. Digestive system tumours","author":"WHO Classification of Tumours Editorial Board","year":"2019","unstructured":"WHO Classification of Tumours Editorial Board. WHO classification of tumours. Digestive system tumours. 5th ed. Lyon: IARC; 2019. pp. 260\u20132.","edition":"5"},{"issue":"1","key":"13876_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/hep.29789","volume":"68","author":"E Brunt","year":"2018","unstructured":"Brunt E, Aishima S, Clavien PA, Fowler K, Goodman Z, Gores G, et al. cHCC-CCA: consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. Hepatology. 2018;68(1):113\u201326.","journal-title":"Hepatology"},{"issue":"2","key":"13876_CR26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/hep.510270239","volume":"27","author":"S Ohguchi","year":"1998","unstructured":"Ohguchi S, Nakatsukasa H, Higashi T, Ashida K, Nouso K, Ishizaki M, et al. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy. Hepatology. 1998;27(2):599\u2013607.","journal-title":"Hepatology"},{"issue":"6","key":"13876_CR27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.hbpd.2020.07.004","volume":"19","author":"D Schizas","year":"2020","unstructured":"Schizas D, Mastoraki A, Routsi E, Papapanou M, Tsapralis D, Vassiliu P, et al. Combined hepatocellular-cholangiocarcinoma: an update on epidemiology, classification, diagnosis and management. Hepatobiliary Pancreat Dis Int. 2020;19(6):515\u201323.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"10","key":"13876_CR28","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.6004\/jnccn.2018.7053","volume":"16","author":"NA Trikalinos","year":"2018","unstructured":"Trikalinos NA, Zhou A, Doyle MBM, Fowler KJ, Morton A, Vachharajani N, et al. Systemic therapy for combined Hepatocellular-Cholangiocarcinoma: A Single-Institution experience. J Natl Compr Canc Netw. 2018;16(10):1193\u20139.","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"13876_CR29","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1111\/cas.13656","volume":"109","author":"S Kobayashi","year":"2018","unstructured":"Kobayashi S, Terashima T, Shiba S, Yoshida Y, Yamada I, Iwadou S, et al. Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma. Cancer Sci. 2018;109(8):2549\u201357.","journal-title":"Cancer Sci"},{"issue":"2","key":"13876_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.21037\/jgo.2017.03.03","volume":"8","author":"JE Rogers","year":"2017","unstructured":"Rogers JE, Bolonesi RM, Rashid A, Elsayes KM, Elbanan MG, Law L, et al. Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy. J Gastrointest Oncol. 2017;8(2):347\u201351.","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"13876_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/bjc.2017.413","volume":"118","author":"M Salimon","year":"2018","unstructured":"Salimon M, Prieux-Klotz C, Tougeron D, Hautefeuille V, Caulet M, Gournay J, et al. Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study. Br J Cancer. 2018;118(3):325\u201330.","journal-title":"Br J Cancer"},{"issue":"6","key":"13876_CR32","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1001\/jamaoncol.2019.0270","volume":"5","author":"RT Shroff","year":"2019","unstructured":"Shroff RT, Javle MM, Xiao L, Kaseb AO, Varadhachary GR, Wolff RA, et al. Gemcitabine, cisplatin, and nab-Paclitaxel for the treatment of advanced biliary tract cancers: A phase 2 clinical trial. JAMA Oncol. 2019;5(6):824\u201330.","journal-title":"JAMA Oncol"},{"issue":"7","key":"13876_CR33","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.ejca.2012.12.002","volume":"49","author":"D Yamada","year":"2013","unstructured":"Yamada D, Kobayashi S, Wada H, Kawamoto K, Marubashi S, Eguchi H, et al. Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer. Eur J Cancer. 2013;49(7):1725\u201340.","journal-title":"Eur J Cancer"},{"issue":"7952","key":"13876_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41586-023-05758-6","volume":"615","author":"AD Weems","year":"2023","unstructured":"Weems AD, Welf ES, Driscoll MK, Zhou FY, Mazloom-Farsibaf H, Chang BJ, et al. Blebs promote cell survival by assembling oncogenic signalling hubs. Nature. 2023;615(7952):517\u201325.","journal-title":"Nature"},{"issue":"8","key":"13876_CR35","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.3390\/cancers12082308","volume":"12","author":"A Massa","year":"2020","unstructured":"Massa A, Varamo C, Vita F, Tavolari S, Peraldo-Neia C, Brandi G, et al. Evolution of the experimental models of cholangiocarcinoma. Cancers (Basel). 2020;12(8):2308.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"13876_CR36","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1101\/pdb.top073585","volume":"2014","author":"LD Shultz","year":"2014","unstructured":"Shultz LD, Goodwin N, Ishikawa F, Hosur V, Lyons BL, Greiner DL. Human cancer growth and therapy in immunodeficient mouse models. Cold Spring Harb Protoc. 2014;2014(7):694\u2013708.","journal-title":"Cold Spring Harb Protoc"},{"issue":"10","key":"13876_CR37","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","volume":"174","author":"LD Shultz","year":"2005","unstructured":"Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, et al. Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human Hemopoietic stem cells. J Immunol. 2005;174(10):6477\u201389.","journal-title":"J Immunol"},{"issue":"1","key":"13876_CR38","doi-asserted-by":"publisher","first-page":"21439","DOI":"10.1038\/s41598-024-72830-0","volume":"14","author":"C Chai","year":"2024","unstructured":"Chai C, Tang H, Miao X, Chen T, Su Y, Li L, et al. Establishment and characterization of a novel human gallbladder cancer cell line, GBC-X1. Sci Rep. 2024;14(1):21439.","journal-title":"Sci Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13876-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13876-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13876-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T09:23:05Z","timestamp":1741944185000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13876-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13876"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13876-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the First Hospital of Lanzhou University (LDYYLL2022-345). Informed consent was obtained from the patient. The animal procedures were approved by the Medical Animal Experiment Ethics Committee of the First Hospital of Lanzhou University (LDYYLL2022-345).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We have obtained consents to publish this paper from all the participants of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"472"}}